Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISAL 2019 | Intensive care for CAR-T: bridge to treatment and response

Michael von Bergwelt • 15 Mar 2019
ISAL 2019
General Leukemia CAR-T

The importance of intensive medicine in the management of patients treated with CAR T-cells should not be underestimated. Speaking from the International Symposium on Acute Leukemias (ISAL) 2019, held in Munich, Germany, Michael von Bergwelt, MD, PhD, of LMU Hospital Munich, Munich, Germany, discusses the importance of intensive care in this field, highlighting the capacity, resources and training issues that need to be addressed.

More from Michael von Bergwelt

Increase in cancer patient transfers to the ICU: what does it come down to?
2:25
Increase in cancer patient transfers to the ICU: what does it come down to?
Michael von Bergwelt • 10 Jul 2019
EuroCARTForce: a platform for progress
2:33
EuroCARTForce: a platform for progress
Michael von Bergwelt • 10 Jul 2019
Preparing the critical care workforce for CAR-T
1:14
Preparing the critical care workforce for CAR-T
Michael von Bergwelt • 10 Jul 2019
Learnings from a CAR-T center: leukapheresis, bridging therapy, toxicities & more
3:43
Learnings from a CAR-T center: leukapheresis, bridging therapy, toxicities & more
Michael von Bergwelt • 15 Mar 2019

Related Videos

Unmet needs in CLL genomics: heterogeneity and clinical impact
1:11
Unmet needs in CLL genomics: heterogeneity and clinical impact
Elias Campo • 16 Oct 2026
Insights into key topics most likely to impact day-to-day CLL management
1:40
Insights into key topics most likely to impact day-to-day CLL management
Alessandra Ferrajoli • 16 Oct 2026
Translating current CLL evidence into national guidelines: which gaps remain?
3:33
Translating current CLL evidence into national guidelines: which gaps remain?
Mary Ann Anderson • 16 Oct 2026
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
2:40
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
Philip Thompson • 22 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals